Fifty years of phenylketonuria newborn screening - A great success for many, but what about the rest?

Molecular Genetics and Metabolism

Volumn 113, Issue 1, 2014, Pages 8-10

  Groselj, Urh ^a   Tansek, Mojca Zerjav ^a   Battelino, Tadej ^a,b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Guthrie test; Newborn screening; Phenylketonuria

Indexed keywords

CONGENITAL HYPOTHYROIDISM; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; HEALTH CARE POLICY; HUMAN; MENTAL DEFICIENCY; NEWBORN; NEWBORN SCREENING; NOTE; PHENYLKETONURIA; HISTORY; PHENYLKETONURIAS;

DEVELOPING COUNTRIES; HISTORY, 20TH CENTURY; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PHENYLKETONURIAS;

EID: 84908393530     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2014.07.019     Document Type: Note

References (21)

1. Folling A. Uber Ausscheidung von Phenylbrenztraubensaure in den Harn als Stoff wechselanomalie in Verbindung mit Inbicillitat. Ztschr. Physiol. Chem. 1934, 227:169.
2. Blau N., van Spronsen F.J., Levy H.L. Phenylketonuria. Lancet 2010, 376:1417-1427.
3. Penrose L.S. Phenylketonuria - a problem in eugenics. Ann. Hum. Genet. 1998, 62:193-202.
4. Bickel H., Gerrard J.W., Hickmans E.M. Influence of phenylalanine intake on phenylketonuria. Lancet 1953, 2:812-819.
5. Scriver C.R. The PAH gene, phenylketonuria, and a paradigm shift. Hum. Mutat. 2007, 28:831-845.
6. Brosco J.P., Paul D.B. The political history of PKU: reflections on 50years of newborn screening. Pediatrics 2013, 132:987-989.
7. Guthrie R., Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963, 32:338-343.
8. Battelino T., Krzisnik C., Pavlin K. Early detection and follow up of children with phenylketonuria in Slovenia. Zdrav. Vestn. 1994, 63:25-28.
9. Groselj U., Zerjav Tansek M., Smon A., Angelkova N., Anton D., Baric I., Djordjevic M., Grimci L., Ivanova M., Kadam A., Kotori V.M., Maksic H., Marginean O., Margineanu O., Milijanovic O., Moldovanu F., Muresan M., Murko S., Nanu M., Lampret B.R., Samardzic M., Sarnavka V., Savov A., Stojiljkovic M., Suzic B., Tincheva R., Tahirovic H., Toromanovic A., Usurelu N., Battelino T. Newborn screening in southeastern Europe. Mol. Genet. Metab. 2014, 113:45-48.
10. Khemir S., El Asmi M., Sanhaji H., Feki M., Jemaa R., Tebib N., Dhondt J.L., Ben Dridi M.F., Mebazaa A., Kaabachi N. Phenylketonuria is still a major cause of mental retardation in Tunisia despite the possibility of treatment. Clin. Neurol. Neurosurg. 2011, 113:727-730.
11. Karam P.E., Daher R.T., Moller L.B., Mikati M.A. Experience with hyperphenylalaninemia in a developing country: unusual clinical manifestations and a novel gene mutation. J. Child Neurol. 2011, 26:142-146.
12. Murad H., Dabboul A., Moassas F., Alasmar D., Al-Achkar W. Mutation spectrum of phenylketonuria in Syrian population: genotype-phenotype correlation. Gene 2013, 528:241-247.
13. Sladkevicius E., Pollitt R.J., Mgadmi A., Guest J.F. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya. Appl. Health Econ. Health Policy 2010, 8:407-420.
14. Shi X.T., Cai J., Wang Y.Y., Tu W.J., Wang W.P., Gong L.M., Wang D.W., Ye Y.T., Fang S.G., Jing P.W. Newborn screening for inborn errors of metabolism in mainland china: 30years of experience. JIMD Rep. 2012, 6:79-83.
15. International Society for Neonatal Screening (ISNS). Available at: (Accessed on July 15, 2014). http://www.isns-neoscreening.org/.
16. Loeber J.G., Burgard P., Cornel M.C., Rigter T., Weinreich S.S., Rupp K., Hoffmann G.F., Vittozzi L. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result. J. Inherit. Metab. Dis. 2012, 35:603-611.
17. Burgard P., Rupp K., Lindner M., Haege G., Rigter T., Weinreich S.S., Loeber J.G., Taruscio D., Vittozzi L., Cornel M.C., Hoffmann G.F. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance. J. Inherit. Metab. Dis. 2012, 35:613-625.
18. Padilla C.D., Therrell B.L. Working Group of the Asia Pacific Society for Human Genetics on Consolidating Newborn Screening Efforts in the Asia Pacific Region. Consolidating newborn screening efforts in the Asia Pacific region: networking and shared education. J. Community Genet. 2012, 3:35-45.
19. Krotoski D., Namaste S., Raouf R.K., El Nekhely I., Hindi-Alexander M., Engelson G., Hanson J.W., Howell R.R., MENA NBS Steering Committee Conference report: second conference of the Middle East and North Africa newborn screening initiative: partnerships for sustainable newborn screening infrastructure and research opportunities. Genet. Med. 2009, 11:663-668.
20. Padilla C.D., Krotoski D., Therrell B.L. Newborn screening progress in developing countries-overcoming internal barriers. Semin. Perinatol. 2010, 34:145-155.
21. Camp K.M., Parisi M.A., Acosta P.B., Berry G.T., Bilder D.A., Blau N., Bodamer O.A., Brosco J.P., Brown C.S., Burlina A.B., Burton B.K., Chang C.S., Coates P.M., Cunningham A.C., Dobrowolski S.F., Ferguson J.H., Franklin T.D., Frazier D.M., Grange D.K., Greene C.L., Groft S.C., Harding C.O., Howell R.R., Huntington K.L., Hyatt-Knorr H.D., Jevaji I.P., Levy H.L., Lichter-Konecki U., Lindegren M.L., Lloyd-Puryear M.A., Matalon K., MacDonald A., McPheeters M.L., Mitchell J.J., Mofidi S., Moseley K.D., Mueller C.M., Mulberg A.E., Nerurkar L.S., Ogata B.N., Pariser A.R., Prasad S., Pridjian G., Rasmussen S.A., Reddy U.M., Rohr F.J., Singh R.H., Sirrs S.M., Stremer S.E., Tagle D.A., Thompson S.M., Urv T.K., Utz J.R., van Spronsen F., Vockley J., Waisbren S.E., Weglicki L.S., White D.A., Whitley C.B., Wilfond B.S., Yannicelli S., Young J.M. Phenylketonuria Scientific Review Conference: state of the science and future research needs. Mol. Genet. Metab. 2014, 112:87-122.